Outcomes with sacubitril/valsartan in outpatients with heart failure and reduced ejection fraction: The ARIADNE registry

ConclusionsThis large HFrEF European registry provides a contemporary outcome profile of outpatients with HFrEF treated with or without sacubitril/valsartan. In a real-world setting, sacubitril/valsartan was associated with an improvement of symptoms in patients with HFrEF compared with the conventional HFrEF treatment.

Source: ESC Heart Failure - September 15, 2022 Category: Cardiology Authors: Aldo P. Maggioni, Andrew L. Clark, Vivencio Barrios, Thibaud Damy, Jaroslaw Drozdz, Candida Fonseca, Lars H. Lund, Stefanie Kalus, Philippe C. Ferber, Rizwan I. Hussain, Cornelia Koch, Uwe Zeymer, on behalf of the ARIADNE investigators Tags: Original Article Source Type: research